Just watched a Scholz (PCRI) video posted last week about PSA. He said multiple times that PSA should reach a nadir of <0.1 after 4-5 months on 1st generation ADT and that if it didn't "something's wrong, that is an unusual type of prostate cancer that has some hormone resistance and studies over and over shown at the prognosis of those individuals is for lower cure rates or more recurrence."
Any thoughts on that statement in general, not related to my own case mentioned below?
update: Tanya Dorff at City of Hope answers a similar question Darryl asked in the video he posted below, her thoughts are at the 23:17 mark.
The above is all I'm really seeking in this thread...feel free to comment on what's below, but that's not really my point here....
My personal interest in this is that I already know I have an unusual (rare) cancer, it's ductal type, that never expressed much PSA (1.1 highest ever until TURP surgery caused trauma), but my PSA after 5 months on Lupron was still 0.944. Wondering what not making the nadir in that timeframe means in this situation.
I was on Lupron only from August to early January, when I started Triplet Therapy at City of Hope. Interestingly, after 4 weeks on NUBEQA and 3 weeks after first docetaxel infusion it dropped to 0.186. After 2nd chemo, down to 0.085, and after 3rd chemo 0.047.
I don't trust PSA as a good indicator of my metastatic PCa in the bones, since an actual bone biopsy showed adenocarcinoma that was PSMA-Positve and PSA-Negative, but it's still an interesting thought journey.